您的位置: 首页 > 农业专利 > 详情页

REGIMEN ADHERENCE MEASURE FOR INSULIN TREATMENT BASED ON GLUCOSE MEASUREMENTS AND INSULIN PEN DATA
专利权人:
Novo Nordisk A/S
发明人:
Henrik Bengtsson,Tinna Bjoerk Aradottir
申请号:
US16307098
公开号:
US20200305788A1
申请日:
2017.06.22
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Systems and methods are provided for adjusting a standing insulin medicament dosage regimen for a subject. Fasting events are Device for adjusting a standing insulin regimen identified using autonomous timestamped glucose measurements of the subject in a first data set. A second data set, from one or more insulin pens used to apply the standing regimen, comprises records, each record comprising a timestamped event specifying an amount of injected insulin medicament. Each fasting event is characterized as adherent or nonadherent. A fasting event is adherent when the second data set includes one or more records that temporally and quantitatively establish adherence with the standing regimen during the fasting event. Conversely, a fasting event is nonadherent when the second data set fails to temporally and quantitatively establish adherence with the standing regimen. Dosages in the standing regimen are adjusted using glucose measurements contemporaneous with adherent fasting events and by excluding glucose measurements contemporaneous with nonadherent fasting events.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充